The Centers for Medicare and Medicaid Services recently announced major price reductions for 15 widely prescribed medications, including popular drugs like Ozempic and Wegovy. These negotiated prices will take effect in 2027 and represent significant savings for both the Medicare program and the millions of patients who rely on these medications. For healthcare providers and […]
Calquence, CMS, Ibrance, Janumet, Medicare, Medicare Part D, Negotiated Prices, Ofev, Ozempic, Pomalyst, Rybelsus, Tradjenta, Wegovy, Xtandi
The One Big Beautiful Bill Act, officially designated as H.R. 1 in the 119th Congress, represents one of the most significant pieces of domestic policy legislation in recent years. The House July 3 voted 218-214 to pass the final version of the One Big Beautiful Bill Act (H.R. 1), which enacts many of President Trump’s […]
Coverage Loss, DJT, Donald J. Trump, Donald Trump, Federal Cuts, Medicaid, Medicaid Changes, Medicaid Fraud, Medicaid-Specific Impact, OBBBA, One Big Beautiful Bill Act, Trump, Work Requirement, Work Requirement for Medicaid